Katy Shurilla
Physician Assistant · Youngstown, OHNPI 1538304381
Payments from drug & device makers
Across 272 payments — averaging $17.50 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Lilly USA, LLC$735
- Novo Nordisk$605
- Bayer$502
- AbbVie$425
- Abbott$377
- Dexcom, Inc.$258
- plus $2K from 33 others
What the payments were for
- Food & beverage$4,71099%
- Education$491%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Lilly USA, LLC | 44 | $735 |
| Novo Nordisk | 45 | $605 |
| Bayer | 39 | $502 |
| AbbVie | 28 | $425 |
| Abbott | 19 | $377 |
| Dexcom, Inc. | 9 | $258 |
| Boehringer Ingelheim | 11 | $214 |
| Ascendis Pharma Endocrinology Inc | 6 | $141 |
| Xeris Pharmaceuticals, Inc. | 6 | $114 |
| Sanofi-aventis U.S. LLC | 5 | $107 |
| Recordati_rare_diseases_inc. | 4 | $83 |
| Amgen | 4 | $76 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 3 | $75 |
| Pfizer | 2 | $73 |
| Amneal Pharmaceuticals LLC | 3 | $71 |
| Antares Pharma, Inc. | 3 | $70 |
| Novartis | 3 | $66 |
| Corcept Therapeutics | 3 | $63 |
| Otsuka America Pharmaceutical, Inc. | 3 | $53 |
| Neurocrine Biosciences, Inc. | 3 | $53 |
| BETA Bionics, Inc. | 2 | $52 |
| Kyowa Kirin, Inc. | 2 | $51 |
| Verity Pharmaceuticals Inc. | 2 | $49 |
| Insulet Corporation | 2 | $45 |
| Tandem Diabetes Care, Inc. | 3 | $40 |
| IBSA Pharma Inc. | 2 | $39 |
| Teva Pharmaceuticals USA, Inc. | 2 | $36 |
| Mannkind Corporation | 1 | $34 |
| Cequr Corporation | 1 | $33 |
| Chiesi USA, Inc. | 2 | $32 |
| Azurity Pharmaceuticals, Inc. | 2 | $32 |
| Medtronic | 1 | $27 |
| Intrabio Inc | 1 | $25 |
| Halozyme Inc | 1 | $21 |
| Acella Pharmaceuticals, LLC | 1 | $19 |
| Lundbeck LLC | 1 | $18 |
| Amryt Pharma Holdings Ltd | 1 | $16 |
| Ascensia Diabetes Care US Inc. | 1 | $14 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$4,759 in reported general payments places this provider in the 90th percentile of 4,098 physician assistant providers in Ohio.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| OzempicSemaglutide | 295 | $432,409 |
| JardianceEmpagliflozin | 206 | $256,870 |
| MounjaroTirzepatide | 89 | $124,959 |
| TrulicityDulaglutide | 78 | $107,129 |
| Toujeo Max SolostarInsulin Glargine,hum.Rec.Anlog | 48 | $96,879 |
| Tresiba Flextouch U-200Insulin Degludec | 48 | $68,468 |
| Humulin R U-500Insulin Regular, Human | 22 | $60,412 |
| RybelsusSemaglutide | 32 | $48,973 |
| Omnipod 5 Dexg7g6 Pods (Gen 5)Insulin Pump Cart,auto,bt,g6/7 | 42 | $48,667 |
| Fiasp FlextouchInsulin Aspart (Niacinamide) | 24 | $48,659 |
| Humalog Kwikpen U-100Insulin Lispro | 115 | $47,612 |
| FarxigaDapagliflozin Propanediol | 63 | $45,179 |
| Lantus SolostarInsulin Glargine,hum.Rec.Anlog | 212 | $43,791 |
| Tresiba Flextouch U-100Insulin Degludec | 38 | $41,535 |
| Humulin R U-500 KwikpenInsulin Regular, Human | 28 | $34,844 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Novo NordiskOzempic, Rybelsus, Novolog | $605 | $484,486342 claims |
| Boehringer IngelheimJardiance, Tradjenta | $214 | $274,456231 claims |
| Lilly USA, LLCMounjaro, Trulicity, Humalog, Humalog Mix 75-25, Humulin 70-30 | $735 | $255,505230 claims |
| Sanofi-aventis U.S. LLCSoliqua 100-33, Lantus | $107 | $16,58436 claims |
| AbbVieSynthroid | $425 | $4,61583 claims |
| Amneal Pharmaceuticals LLCLevothyroxine Sodium | $71 | $2,410194 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 4,098 physician assistant providers in Ohio.
Other physician assistant in Youngstown
- Steven WurzelbacherCincinnati$309K
- Emily AnkromDayton$192K
- Amanda MaggartWorthington$164K
- Megan SevillaMayfield Heights$132K
- Erin StrculaBelpre$106K
- Natalie WalkupSylvania$105K
- Sarah LaubNew Albany$100K
- Jessica RhominskiCanal Winchester$78K
- Alan OdonnellCincinnati$71K
- Brook GramBeloit$52K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.